Cargando…

Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease

Chronic kidney disease (CKD) is characterized by gut dysbiosis with a decrease in short-chain fatty acid (SCFA)-producing bacteria. Levels of protein-bound uremic toxins (PBUTs) and post-translational modifications (PTMs) of albumin increase with CKD, both risk factors for cardiovascular morbidity a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steenbeke, Mieke, Valkenburg, Sophie, Gryp, Tessa, Van Biesen, Wim, Delanghe, Joris R., Speeckaert, Marijn M., Glorieux, Griet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625482/ https://www.ncbi.nlm.nih.gov/pubmed/34822593 http://dx.doi.org/10.3390/toxins13110809

Ejemplares similares

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Carbamoylated Nail Proteins as Assessed by Near-Infrared Analysis Are Associated with Load of Uremic Toxins and Mortality in Hemodialysis Patients
por: De Bruyne, Sander, et al.
Publicado: (2020)

Dietary Advanced Glycation End Products in an Elderly Population with Diabetic Nephropathy: An Exploratory Investigation
por: Steenbeke, Mieke, et al.
Publicado: (2022)

UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2020)

Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients
por: Gryp, Tessa, et al.
Publicado: (2020)

Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis
por: Eloot, Sunny, et al.
Publicado: (2016)

Measured Glomerular Filtration Rate: The Query for a Workable Golden Standard Technique
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes
por: Deltombe, Olivier, et al.
Publicado: (2019)

Gut Microbiome Profiling Uncovers a Lower Abundance of Butyricicoccus in Advanced Stages of Chronic Kidney Disease
por: Gryp, Tessa, et al.
Publicado: (2021)

Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease
por: Glorieux, Griet, et al.
Publicado: (2020)

Does the Adequacy Parameter Kt/V(urea) Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
por: Eloot, Sunny, et al.
Publicado: (2013)

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
por: Deltombe, Olivier, et al.
Publicado: (2015)

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients
por: Eloot, Sunny, et al.
Publicado: (2017)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

Vitamin D binding protein and endothelial injury after hematopoietic stem cell transplantation: an actin scavenger with a lipid-bound character
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease
por: Chinnappa, Shanmugakumar, et al.
Publicado: (2018)

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
por: Liabeuf, Sophie, et al.
Publicado: (2013)

Immunosenescence and Immune Exhaustion Are Associated with Levels of Protein-Bound Uremic Toxins in Patients on Hemodialysis
por: Tourountzis, Theodoros, et al.
Publicado: (2023)

Estimating the Level of Carbamoylated Plasma Non-High-Density Lipoproteins Using Infrared Spectroscopy
por: Delanghe, Sigurd E., et al.
Publicado: (2019)

Detection and Characterization of a Biochemical Signature Associated with Diabetic Nephropathy Using Near-infrared Spectroscopy on Tissue Sections
por: De Bruyne, Sander, et al.
Publicado: (2019)

p-Cresyl Sulfate
por: Gryp, Tessa, et al.
Publicado: (2017)

An unusual case of (pseudo)hypertriglyceridaemia
por: Speeckaert, Marijn M., et al.
Publicado: (2010)

Preanalytical requirements of urinalysis
por: Delanghe, Joris, et al.
Publicado: (2014)

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
por: Vanholder, Raymond, et al.
Publicado: (2008)

Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2020)

Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

The biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Protein-bound solute removal during extended multipass versus standard hemodialysis
por: Eloot, Sunny, et al.
Publicado: (2015)

Creatinine determination according to Jaffe—what does it stand for?
por: Delanghe, Joris R., et al.
Publicado: (2011)

A key role for vitamin D binding protein in COVID-19?
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Vitamin D binding protein: A key regulator of vitamin D deficiency among patients with pneumonia
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Host polymorphisms and COVID-19 infection
por: Delanghe, Joris R., et al.
Publicado: (2022)

Association between low vitamin D and COVID-19: don’t forget the vitamin D binding protein
por: Speeckaert, Marijn M., et al.
Publicado: (2020)

Commentary: Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?
por: Speeckaert, Marijn M., et al.
Publicado: (2022)

Commentary: Serum Vitamin D Levels Are Associated With Increased COVID-19 Severity and Mortality Independent of Whole-Body and Visceral Adiposity
por: Speeckaert, Marijn M., et al.
Publicado: (2022)

The potential significance of vitamin D binding protein polymorphism in COVID-19
por: Speeckaert, Marijn M, et al.
Publicado: (2021)

Vitamin D binding protein: A polymorphic protein with actin-binding capacity in COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2022)

Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality
por: Speeckaert, Marijn M., et al.
Publicado: (2022)

Commentary: Vitamin D Status in Relation to the Clinical Outcome of Hospitalized COVID-19 Patients
por: Speeckaert, Marijn M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j2fpfbalab3sfjmdm6bl7k7j04